Bye CF­DA: Chi­na's drug reg­u­la­tor to take new shape in ma­jor gov­ern­ment re­struc­tur­ing

A sweep­ing gov­ern­ment re­or­ga­ni­za­tion has re­wo­ven the Chi­na Food and Drug Ad­min­is­tra­tion in­to the fab­ric of an over­ar­ch­ing mar­ket su­per­vi­sion ad­min­is­tra­tion, giv­ing birth to a drug reg­u­la­tor un­der its purview.

The changes mean that af­ter five years of di­rect­ly re­port­ing to the State Coun­cil, the CF­DA will no longer be a stand­alone agency. The new­ly cre­at­ed mar­ket su­per­vi­sion ad­min­is­tra­tion will have a broad man­date cov­er­ing an­ti-mo­nop­oly laws, price con­trol, con­sumer goods qual­i­ty and safe­ty, etc — and that in­cludes every­thing food-re­lat­ed. It will, how­ev­er, leave the mat­ters of drug ap­proval to a sub-ad­min­is­tra­tion ded­i­cat­ed to drug reg­u­la­tion.

Endpoints News

Unlock this article instantly by becoming a free subscriber.

You’ll get access to free articles each month, plus you can customize what newsletters get delivered to your inbox each week, including breaking news.